Gene · 55869
Papers3,134
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 3,134
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Carnitine Protects against MPP+-Induced Neurotoxicity and Inflammation by Promoting Primary Ciliogenesis in SH-SY5Y Cells. | Cells | 2022 | 36078130 | PubTator, text mining | PubMed |
| Functional Drug Screening of Small Molecule Inhibitors of Epigenetic Modifiers in Refractory AML Patients. | Cancers (Basel) | 2022 | 36077629 | PubTator, text mining | PubMed |
| A Therapeutic Perspective of HDAC8 in Different Diseases: An Overview of Selective Inhibitors. | Int J Mol Sci | 2022 | 36077415 | PubTator, text mining | PubMed |
| Preliminary Characterization of the Epigenetic Modulation in the Human Mesenchymal Stem Cells during Chondrogenic Process. | Int J Mol Sci | 2022 | 36077266 | PubTator, text mining | PubMed |
| Histone Deacetylases Function in the Control of Early Hematopoiesis and Erythropoiesis. | Int J Mol Sci | 2022 | 36077192 | PubTator, text mining | PubMed |
| Inhibition of Class I Histone Deacetylase Activity Blocks the Induction of TNFAIP3 Both Directly and Indirectly via the Suppression of Endogenous TNF-α. | Int J Mol Sci | 2022 | 36077149 | PubTator, text mining | PubMed |
| Histone Deacetylases Cooperate with NF-κB to Support the Immediate Migratory Response after Zebrafish Pronephros Injury. | Int J Mol Sci | 2022 | 36076983 | PubTator, text mining | PubMed |
| Advances of Epigenetic Biomarkers and Epigenome Editing for Early Diagnosis in Breast Cancer. | Int J Mol Sci | 2022 | 36076918 | PubTator, text mining | PubMed |
| Integrated Analysis Reveals the Potential Significance of HDAC Family Genes in Lung Adenocarcinoma. | Front Genet | 2022 | 36072664 | PubTator, text mining | PubMed |
| Multi-omics analysis of naïve B cells of patients harboring the C104R mutation in TACI. | Front Immunol | 2022 | 36072607 | PubTator, text mining | PubMed |
| Discovery of a 2,6-diarylpyridine-based hydroxamic acid derivative as novel histone deacetylase 8 and tubulin dual inhibitor for the treatment of neuroblastoma. | Bioorg Chem | 2022 | 36070628 | PubTator, text mining | PubMed |
| Enzymatic independent role of sphingosine kinase 2 in regulating the expression of type I interferon during influenza A virus infection. | PLoS Pathog | 2022 | 36070294 | PubTator, text mining | PubMed |
| 3-Chloro-5-Substituted-1,2,4-Thiadiazoles (TDZs) as Selective and Efficient Protein Thiol Modifiers. | Chembiochem | 2022 | 36066474 | PubTator, text mining | PubMed |
| Specific epigenetic regulators serve as potential therapeutic targets in idiopathic pulmonary fibrosis. | Heliyon | 2022 | 36061031 | PubTator, text mining | PubMed |
| Heme oxygenase 1 overexpression induces immune evasion of acute myeloid leukemia against natural killer cells by inhibiting CD48. | J Transl Med | 2022 | 36058936 | PubTator, text mining | PubMed |
| Case Report: A case of uterine leiomyosarcoma metastasized to the vena cava, excised with the aid of preoperative CT three-dimensional imaging. | Front Oncol | 2022 | 36052267 | PubTator, text mining | PubMed |
| Reversible epigenetic alterations regulate class I HLA loss in prostate cancer. | Commun Biol | 2022 | 36050516 | PubTator, text mining | PubMed |
| HDAC8 Promotes Liver Metastasis of Colorectal Cancer via Inhibition of IRF1 and Upregulation of SUCNR1. | Oxid Med Cell Longev | 2022 | 36035205 | PubTator, text mining | PubMed |
| Potential of histone deacetylase inhibitors in the control and regulation of prostate, breast and ovarian cancer. | Front Chem | 2022 | 36034650 | PubTator, text mining | PubMed |
| Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy. | J Hematol Oncol | 2022 | 36031601 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55869/papers?page=31